Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

Gram-positive bacteria have become the predominant infecting organisms in granulocytopenic cancer patients. Empiric antibiotic regimens used in febrile neutropenic patients often include an extended-spectrum cephalosporin, but the response to therapy in gram-positive coccal bacteremia has been unsat...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Cometta, A, Zinner, S, de Bock, R, Calandra, T, Gaya, H, Klastersky, J, Langenaeken, J, Paesmans, M, Viscoli, C, Glauser, M P
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162558/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726513/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.445
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!